CONGENITAL HIP DYSPLASIA
Clinical trials for CONGENITAL HIP DYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HIP DYSPLASIA trials appear
Sign up with your email to follow new studies for CONGENITAL HIP DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hip implant under study for arthritis sufferers
Disease control Recruiting nowThis study is testing a new hip replacement system called Emphasys Hip Solutions in 30 people with hip osteoarthritis. Researchers will use special X-ray imaging to see how well the implant stays in place over two years. The goal is to make sure the implant is stable and works we…
Matched conditions: CONGENITAL HIP DYSPLASIA
Phase: NA • Sponsor: Canadian Radiostereometric Analysis Network • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hip implant under surveillance: will it last?
Disease control Recruiting nowThis study is tracking 550 adults aged 18–75 who receive the Medacta SMS femoral stem during total hip replacement. Researchers will monitor how long the implant lasts, how well the hip functions, patient satisfaction, and quality of life. The goal is to confirm the device's safe…
Matched conditions: CONGENITAL HIP DYSPLASIA
Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hip resurfacing device tracked for 10 years in 150 patients
Disease control Recruiting nowThis study follows 150 people aged 18 to 65 who receive the ROMAX hip resurfacing system to treat hip arthritis or dysplasia. Researchers will track how long the implant lasts and how well the hip functions over 10 years. The goal is to monitor the device's safety and performance…
Matched conditions: CONGENITAL HIP DYSPLASIA
Sponsor: Medacta International SA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC